Duration of penicillin prophylaxis in sickle cell anemia: Issues and controversies

Pharmacotherapy

Volumn 20, Issue 1 I, 2000, Pages 110-117

  Pai, Vinita B ^a   Nahata, Milap C ^b  

^a IDAHO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN V POTASSIUM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ASPLENIA; BACTERIAL INFECTION; CHILD; CONTROLLED STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NAUSEA; PROPHYLAXIS; SEPTICEMIA; SHORT SURVEY; SICKLE CELL ANEMIA; STREPTOCOCCUS PNEUMONIAE; VOMITING;

EID: 0033986259     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.1.110.34660     Document Type: Short Survey

References (55)

1. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997;11:762-9.
2. Lane PA. Sickle cell disease. Pediatr Clin North Am 1996;43:639-64.
3. McKie VC. Sickle cell anemia in children: practical issues for the pediatrician. Pediatr Ann 1998;27:521-4.
4. Robinson MG, Watson RJ. Pneumococcal meningitis in sickle-cell anemia. N Engl J Med 1966;274:1006-8.
5. Pearson HA. Sickle cell anemia and serious infections due to encapsulated bacteria. J Infect Dis 1977;136(suppl):S25-30.
6. Ellis EF, Smith RT. The role of the spleen in immunity, with special reference to the post-splenectomy problems in infants. Pediatrics 1966,37:111-19.
7. Schulkind ML, Ellis EF, Smith RT. Effect of antibody upon clearance of 1125 labeled pneumococci by the spleen and liver. Pediatr Res 1967;1:178-84.
8. Brown AK, Sleeper LA, Miller ST, et al. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Arch Pediatr Adolesc Med 1994;148:796-804.
9. Joiner KA, Brown EJ, Frank MM. Complement and bacteria: chemistry and biology in host defense. Annu Rev Immunol 1984;2:461-91.
10. Noel GJ, Katz S, Edelson P. Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity. J Infect Dis 1988;157: 85-90.
11. Rubin LG. Anticapsular antibody requirements for protection against experimental Haemophilus influenzae type b bacteremia after splenectomy. Infect Immunol 1988;56:984-6.
12. Corry JM, Polhill RB Jr, Edmonds SR, Johnston RB Jr. Activity of alternative complement pathway after splenectomy: comparison to activity in sickle cell disease and hypogammaglobulinemia. J Pediatr 1979;95:964-9.
13. U.S. Department of Health and Human Services, Public Health Service, National Heart, Lung and Blood Institute. Management and therapy of sickle cell disease. Bethesda, MD: National Institutes of Health, Division of Blood Diseases and Resources, 1995.
14. Lane PA, O'Connell JL, Kear JL, et al. Functional asplenia in hemoglobin SC disease. Blood 1995;85:2238-44.
15. Rogers ZR, Buchanan GR. Bacteremia in children with sickle hemoglobin C disease and sickle beta+ thalassemia: is prophylactic penicillin necessary? J Pediatr 1995;127:348-53.
16. Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle cell hemoglobinopathies. J Pediatr 1986;109:579-85.
17. American Academy of Pediatrics Committee on Infectious Diseases. Red book. Elk Grove Village, IL: American Academy of Pediatrics, 1997;418-19.
18. John AB, Ramial A, Jackson H, et al. Prevention of pneumococcal infection in children with homozygous sickle cell disease. Br Med J 1984;288:1567-70.
19. Buchanan GR, Siegel JD, Smith SJ, DePasse BM. Oral penicillin prophylaxis in children with impaired splenic function: a study of compliance. Pediatrics 1982;70:926-30.
20. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med 1986;25:1593-99.
21. Falletta JM, Woods GM, Verter JI. Discontinuing penicillin prophylaxis in children with sickle cell anemia. J Pediatr 1995;127:685-90.
22. Teach SJ, Lillis KA, Grossi M. Compliance with penicillin prophylaxis in patients with sickle cell disease. Arch Pediatr Adolesc Med 1998;152:274-8.
23. Pegelow CH, Armstrong FD, Light S, Toledano SR, Davis J. Experience with the use of prophylactic penicillin in children with sickle cell anemia. J Pediatr 1991;118:736-8.
24. Cummins D, Heuschkel R, Davies SC. Penicillin prophylaxis in children with sickle cell disease in Brest. BMJ 1991;302:989-90.
25. Anonymous. Drug topics red book. Montvale, NJ: Medical Economics Co., 1999;479-80.
26. Marton A, Gulyas M, Munoz R, et al Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991;163:542-8.
27. Tan TQ, Mason EO, Kaplan SL. Penicillin-resistant pneumococcal infections in children: a retrospective case-control study. Pediatrics 1993;92:761-7.
28. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-56.
29. Douglas RM, Stuart J. Penicillin-resistant pneumococci and pneumonia. Med J Aust 1975;1:82.
30. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infec Dis J 1995;14:745-50.
31. Boken DJ, Chartrand SA, Goering RV, et al. Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center. Pediatr Infect Dis J 1995;14:879-84.
32. Anonymous. Drug resistant Streptococcus pneumoniae -Kentucky and Tennessee, 1993. MMWR 1994;43:23-6.
33. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
34. Appelbaum PC. Emerging resistance to antimicrobial agents in gram-positive bacteria. Pneumococci. Drugs 1996;51(suppl. 1):1-5.
35. Mazzulli T, Simor AE, Jaeger R, et al. Comparative in vitro activities of several new fluoroquinolones and β-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1990;34:467-9.
36. Spika JS, Facklam RR, Plikaytis BD, et al. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis 1991;163:1273-8.
37. Thornsberry C, Ogilivie P, Kahn JB, et al. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. Diagn Microbiol Infect Dis 1997;29:249-57.
38. Overturf GD, Field R, Lam C, et al. Nasopharyngeal carriage of pneumococci in children with sickle cell disease. Infect Immunol 1980;28:1048-50.
39. Schricker ME, Schreiber JR, Chiarucci K, et al. Absence of antibiotic-resistant Streptococcus pneumoniae pharyngeal colonization in Cleveland children with sickle cell disease. Pediatr Infec Dis 1993;12:775-7.
40. Woods GM, Jorgensen JH, Waclawiw MA, et al. Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. J Pediatr Hematol Oncol 1997;19:327-33.
41. Steele RW, Warrier R, Unkel PJ, et al. Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease. J Pediatr 1996;128:531-5.
42. Hongeng S, Willimas JA, Harris S, et al. Recurrent Streptococcus pneumoniae sepsis in children with sickle cell disease. J Pediatr 1997;130:814-16.
43. Wahlby L, Domellof L. Splenectomy after blunt abdominal trauma. A retrospective study of 413 children. Acta Chir Scand 1981;147:131-5.
44. Ein SH, Shandling B, Simpson JS, et al. The morbidity and mortality of splenectomy in childhood. Ann Surg 1977;185:307-9.
45. Pedersen FK. Postsplenectomy infection in Danish children splenectomized 1968-1978. Acta Paediatr Scand 1983;72:589-95.
46. Pegelow CH, Wilson B, Overturf GD, et al. Infection in splenectomized sickle cell disease patients. Clin Pediatr 1980;19:102-5.
47. Giebink GS, Foker JE, Kim Y, et al. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J Infect Dis 1980;141:404-12.
48. Pradier C, Dunais B, Carsenti-Etesse H, et al. Pneumococcal resistance patterns in Europe. Eur J Clin Microbiol Infect Dis 1997;16:644-7.
49. Welby PL, Keller DS, Cromien JL, et al. Resistance to penicillin and non-beta lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr Infect Dis J 1994;13:281-7.
50. Advisory Committee on Immunization Practice. Prevention of pneumococcal disease. MMWR 1997;46:RR-8.
51. Bjornson AB, Falleta JM, Verter JI, et al. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Pediatr 1996;129:828-35.
52. Vernacchio L, Neufeld EJ, MacDonald K, et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr 1998;133:275-8.
53. Obaro SK, Huo Z, Banya WA, et al. A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children. Pediatr Infect Dis J 1997;16:135-40.
54. Anderson EL, Kennedy DJ, Geldmacher KM, et al. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 1996;128:649-53.
55. Chan CY, Molrine DC, George S, et al. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease. J Infect Dis 1996;173:266-8.